Treatment
Medication clinical trials
We’re tracking 7,144 recruiting studies that include Medication, each written for real people, not researchers, below.
Recruiting studies
- NCT00267501Recruiting
Study collects data and samples to understand eosinophilic conditions
This study collects information and biological samples to better understand what causes certain allergic/eosinophilic conditions. It may help researchers learn mechanisms and improve future care.
Cincinnati, OhioAges Any age - NCT04979338RecruitingPhase 3
Opioid-sparing pain control for gender-affirming surgery
This Phase 3 study tests ways to manage pain during and after gender-affirming surgery while using less opioid medicine. It may help improve comfort after surgery and reduce opioid-related side effects.
Los Angeles, CaliforniaAges 18 years+ - NCT05518604Recruiting
Weight loss and fitness after pregnancy in active-duty women
This study looks at how to support healthy weight loss and physical fitness after having a baby while you’re still on active duty. It may help by testing a structured approach to fitness and planning during the first 18 months after delivery.
Honolulu, HawaiiAges 18–44 - NCT06367920Recruiting
Study of brain MRI data in children with developmental delay
This study looks back at medical records of children and young adults (up to age 20) who had brain MRIs to understand developmental delays. It aims to gather information that could help improve care for kids with similar conditions.
Seongnam-si, Gyeonggi-doAges Up to 20 years - NCT06394739Recruiting
RevCore for blood clots in leg stents
This trial tests a special catheter to remove blood clots that have formed inside a leg vein stent. It may be an option for people who have had a stent in place for more than 6 weeks and have a new clot in certain leg veins.
New Haven, ConnecticutAges 18 years+ - NCT06382675Recruiting
Testing a new plasma filter for blood cleaning treatment
This trial tests a new plasma filter, PX2, used in a procedure called therapeutic plasma exchange (TPE) to clean harmful substances from your blood. It’s for people who already need TPE and can safely use a blood thinner during the treatment.
Aschaffenburg, BavariaAges 18 years+ - NCT06256419Recruiting
Gene testing and exenatide response in Chinese type 2 diabetes patients
This study looks at how certain genes affect the risk of type 2 diabetes and how well the drug exenatide (a GLP-1 receptor agonist) works in Chinese patients. It aims to see if your genetic makeup can predict how you will respond to treatment.
Xuzhou, ChinaAges 25–70 - NCT05729607Recruiting
Gum tissue repair around an implant using two material types
This trial compares two ways of adding gum (soft tissue) around a dental implant—using donor gum tissue versus a different graft material. If you have a healthy implant with some gum recession, this study may help find which approach works better for healing and gum coverage.
Boston, MassachusettsAges 18–99 - NCT06166277Recruiting
Ablation for fainting and slow heartbeat registry
This study tests a procedure called cardioneuroablation for people whose fainting or very slow heartbeat doesn't improve with other treatments. If you are under 60, have no other major heart conditions, and have not had ablation before, it might be an option to reduce or stop your fainting spells.
Chicago, IllinoisAges 18–60 - NCT06382012RecruitingPhase 2/Phase 3
Fosaprepitant for nausea in the emergency room
This study tests if a drug called fosaprepitant can help people in the emergency room whose nausea and vomiting don't improve with standard medicine. It may be an option if you still feel sick 2 hours after your first nausea treatment.
The Bronx, New YorkAges 18 years+ - NCT06383026Recruiting
Hormone Therapy Breast Cancer Screening Pilot
This pilot study tests a new way to screen for breast cancer in people who have taken hormone therapy (like estrogen, progesterone, or testosterone). It aims to include both men and women between 40 and 75, and younger people (30-39) with a family history of breast cancer.
Milwaukee, WisconsinAges 30–75 - NCT06392932Recruiting
Esophageal temperature monitoring during heart ablation
This study tests a new way to monitor the temperature in your esophagus during a standard heart ablation procedure for atrial fibrillation. The goal is to see if the new catheter (Q-DOT Micro) safely heats the heart tissue without harming the esophagus.
Los Angeles, CaliforniaAges 18 years+ - NCT06395506Recruiting
Exercise and creatine for breast cancer survivors
This trial tests if adding creatine supplements to a virtual exercise program helps breast cancer survivors recover after chemotherapy. Participants will attend online exercise sessions three times a week and take creatine by mouth.
Galveston, TexasAges 18–75 - NCT06395389Recruiting
A brief program to help young adults cut back on cannabis
This trial tests a short, one-time program designed to help people ages 18-25 who use cannabis frequently (at least 20 days per month) reduce their use. It may be a good fit if you're not already in treatment and are thinking about making a change.
Charleston, South CarolinaAges 18–25 - NCT06396247RecruitingPhase 2/Phase 3
Daily leg exercises to improve walking
This study tests a simple daily leg-strengthening routine to see if it helps people who have trouble walking short distances. You'll do easy resistance exercises at home, which might make it easier to walk and move around.
Hershey, PennsylvaniaAges 65 years+ - NCT06388148Recruiting
Clot removal for very large strokes
This trial tests a procedure to remove a large blood clot in the brain (mechanical thrombectomy) for people who have a very large stroke. It aims to see if removing the clot can improve recovery, even for those with severe strokes.
Hengyang, HunanAges 18 years+ - NCT06388967Recruiting
Pancreatic cancer detection study
This study is looking at blood or tissue samples from people with pancreatic cancer and from those without it. The goal is to find ways to detect the cancer earlier.
Phoenix, ArizonaAges 18 years+ - NCT06388109Recruiting
Lifesaving support app for HIV care
This trial tests a mobile app designed to help people living with HIV stay engaged in their care. If you are newly diagnosed, have missed appointments, or have had trouble keeping your viral load suppressed, this app could provide the support you need to stay healthy.
Van Nuys, CaliforniaAges 13–34 - NCT06398990Recruiting
Cognitive exercise therapy vs. yoga for teen period pain
This study compares two non-drug treatments—a cognitive exercise therapy approach and yoga—to see which helps reduce pain and improve quality of life in teenagers with period pain. If you are between 10 and 19, have moderate to severe menstrual cramps, and have never given birth, you may be eligible.
Istanbul, AtaşehirAges 10–19 - NCT06399432Recruiting
Mediterranean diet for psoriasis patients on biologic therapy
This study tests whether adding a Mediterranean diet to your psoriasis treatment can improve your skin. You will be asked to follow a heart-healthy diet for several months while taking a new biologic medicine.
Cleveland, OhioAges 18–94 - NCT06383884RecruitingPhase 2
Study of patritumab deruxtecan for NRG1 fusion-positive tumors
This trial tests a new drug called patritumab deruxtecan for people with advanced solid tumors that have an NRG1 fusion. The drug targets a protein called HER3 on cancer cells and may help shrink tumors or slow their growth.
SeoulAges 18 years+ - NCT06384404Recruiting
Surgery First for Osteosarcoma of the Arm or Leg
This trial tests removing the tumor with surgery first, then following up with chemotherapy. It's for people with a new, high-grade osteosarcoma in an arm or leg that hasn't spread.
The Bronx, New YorkAges 5–40 - NCT06380868Recruiting
Guiding Heart Stents in Diabetes Patients
This trial compares two ways to guide heart stent placement in people with diabetes. One method uses a special camera inside the artery (IVI), the other uses standard X-ray pictures. The goal is to see which leads to better outcomes.
Nanjing, JiangsuAges 18–80 - NCT06394570RecruitingPhase 1/Phase 2
Enfortumab vedotin and radiation for bladder cancer
This trial tests a combination of a targeted drug (enfortumab vedotin) and focused radiation before surgery to remove the bladder. It aims to improve outcomes for people with bladder cancer that has not spread beyond the bladder.
Dallas, TexasAges 18 years+
Common questions
- Are there clinical trials studying Medication?
- Yes. Clin2 currently lists 7,144 recruiting studies that include Medication, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Medication trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Medication an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Medication or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.